GPCR University offers two live courses this fall that you won’t want to miss.

Submit poster abstracts via this form; short talks will be selected.

Submit poster abstracts using this form; short talks will be selected from submissions.

Nouvelle-Aquitaine Region Governor GPCR Events, Meetings, and Webinars January 16 - 19, 2024 | 23rd Annual PEP Talk

interactions of the serotonin1A receptor Industry News Neurocrine Biosciences Announces Conference Call

GPCR Ecosystem this fall.

The program is under construction but if you’d like to give a talk or present a poster, email us at Hello

Call for GPCR Papers GPCRs: Signal Transduction. Ends tomorrow - March 31st, 2023.

) Sosei Heptares Receives Approval for Change of Market Listing Segment to the Tokyo Stock Exchange Call

While the program is being finalized, if you're interested in giving a talk or presenting a poster, please

Heptares and Neurocrine Biosciences won Top Out-Licensing Deal on the 8th annual Japan Deal of the Year Call

The cost is $299 and includes: All 4 live Zoom sessions ( 4x 1 hour lecture + 30 mins Q&A) 30-minute GPCR Ecosystem contents and perks, including our forums, private groups, and all Ecosystem members Only Addiction Treatment AEF0117 GPCR Events, Meetings, and Webinars January 16 - 19, 2024 | 23rd Annual PEP Talk

The cost is $299 and includes: All 4 live Zoom sessions ( 4x 1 hour lecture + 30 mins Q&A) 30-minute GPCR Ecosystem contents and perks, including our forums, private groups, and all Ecosystem members Go crop protection company GPCR Events, Meetings, and Webinars January 16 - 19, 2024 | 23rd Annual PEP Talk

G-Protein-Coupled Receptors Industry News Sosei Heptares to take back GPCR agonist after GSK changes course All-rounder In Parkinson’s Treatment GPCR Events, Meetings, and Webinars January 16 - 19, 2024 | 23rd Annual PEP Talk

Discovery and Development GPCR Events, Meetings, and Webinars January 16 - 19, 2024 | 23rd Annual PEP Talk

opportunity to generate proprietary chemo-informatics for GPCR drug discovery - Design Pharmaceuticals Call

We're sending you all the good vibes and a sprinkle of birthday magic for an epic celebration! Team with Key Appointments in US and UK and Announces the Nomination of Clinical Candidate Against MC2 Call

Call for GPCR Papers GPCRs: Signal Transduction Advances in Computational and Chemical Methods to study

The cost is $299 and includes: All 4 live Zoom sessions ( 4x 1 hour lecture + 30 mins Q&A) Complimentary GPCR Ecosystem contents and perks, including our forums, private groups, and all Ecosystem members Go Advance Novel Gene Therapies GPCR Events, Meetings, and Webinars January 16 - 19, 2024 | 23rd Annual PEP Talk

The cost is $299 and includes: All 4 live Zoom sessions ( 4x 1 hour lecture + 30 mins Q&A) Complementary GPCR Ecosystem contents and perks, including our forums, private groups, and all Ecosystem members Go Wishing you all a joyful holiday season and a prosperous New Year! Strengthen Neuroscience Pipeline GPCR Events, Meetings, and Webinars January 16 - 19, 2024 | 23rd Annual PEP Talk

Greetings to all! Terry Kenakin will conduct two back-to-back courses this fall.

and Pharmacology Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call

With just one week left, becoming a premium member is all it takes to benefit from this discount! Crinetics Pharmaceuticals Announces September 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Call

development DeepCure team is excited to welcome Justin Potnick, to our Medicinal Chemistry group Call

phase I clinical study in patients with advanced, recurrent or metastatic solid tumors: the EPRAD study Call

Based on all the information collected, the authors proposed the following multistep model for receptor-β-arrestin Although this study has limitations, such as the absence of the flexible distal C-tail of βArr2 in the

The program is under construction but if you’d like to give a talk or present a poster, email us at Hello

We’re committed to making education accessible to all! Adiso Announces Groundbreaking Research Highlighting ADS024 a Novel Oral Agent for Neuroinflammation Call